Clinical Trials Browser

OTHER × Pancreatic Neoplasms × GSK2256098 × Clear all

NCT02428270 2022-11-01

A Study of GSK2256098 and Trametinib in Advanced Pancreatic Cancer

Phase 2 Completed

Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms